Global Multiple Sclerosis Drugs Market

Transcription

1 Brochure More information from Global Multiple Sclerosis Drugs Market Description: About Multiple Sclerosis and Disease Types Multiple sclerosis is a chronic, inflammatory medical condition that results in demyelination, axonal transection, and neurodegeneration. The myelin sheath is damaged because of an abnormal response by the immune system, which targets neurons within the central nervous system (CNS). It is a potentially debilitating disease in which the damage of the myelin sheath causes disruption in the communication and coordination functions of the body. The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms observed in a patient with multiple sclerosis are fatigue, numbness, spasticity, bladder dysfunction, cognitive changes, emotional changes, and depression. An individual with the severe course of the disease can experience speech problems and movement problems. Multiple sclerosis can be broadly classified into four types: relapsing-remitting multiple sclerosis, secondary-progressive multiple sclerosis, primary-progressive multiple sclerosis, and progressive-relapsing multiple sclerosis. On the basis of the route of drug administration, the Global Multiple Sclerosis Drugs market can be segmented into two: Oral Drugs, and Parenteral Drugs. The analysts forecast the Global Multiple Sclerosis Drugs market to grow at a CAGR of 5.56 percent over the period Covered in this Report This report covers the present scenario and the growth prospects of the Global Multiple Sclerosis Drugs market for the period To calculate the market size, the report considers the revenue generated from the sales of various drugs used for the treatment of multiple sclerosis. The report, the Global Multiple Sclerosis Drugs Market , has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Multiple Sclerosis Drugs market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Key Regions - Americas - APAC - EMEA Key Vendors - Bayer - Biogen Idec - Merck Serono - Novartis - Teva Pharmaceutical Other Prominent Vendors - AB Science - Abbvie - Acorda - Active Biotech - GlaxoSmithKline - Glenmark - Mitsubishi Tanabe - Opexa - Pfizer - Sanofi Market Drivers - Unmet Medical Needs - For a full, detailed list, view this report

2 Market Challenges - Unknown Etiology of the Disease - For a full, detailed list, view this report Market Trends - Introduction of Disease-modifying Drugs - For a full, detailed list, view this report Key Questions Answered in this Report - What will the market size be in 2018 and what will the growth rate be? - What are the Key Market Trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? Contents: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 04. Product Profiles Betaferon/Betaseron/Extavia Avonex/Rebif Fampyra Tecfidera Tysabri Gilenya Copaxone 05. Market Research Methodology 05.1 Market Research Process 05.2 Research Methodology 06. Introduction 06.1 Market Overview 06.2 Market Size and Forecast 06.3 Five Forces Analysis 07. Rate of Incidence and Prevalence 08. Market Segmentation by Molecule Type 08.1 Global Biologics Market Market Size and Forecast 08.2 Global Small Molecules Market Market Size and Forecast 09. Market Segmentation by Route of Administration 09.1 Global Oral Drugs Market Market Size and Forecast 09.2 Global Parenteral Drugs Market Market Size and Forecast 10. Geographical Segmentation 10.1 Multiple Sclerosis Market in the US Market Size and Forecast 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 18.1 Competitive Scenario Key News Mergers and Acquisitions

3 18.2 Market Share Analysis Bayer Biogen Idec Merck Serono Novartis Teva Pharmaceuticals 18.3 Other Prominent Vendors 19. Key Vendor Analysis 19.1 Bayer Key Facts Business Overview Business Segmentation Business Strategy Sales Segmentation by Business Sales by Geographical Segmentation Key Information SWOT Analysis 19.2 Biogen Idec Key Facts Business Overview Business Segmentation by Revenue Geographical Segmentation by Revenue Business Strategy Key Developments SWOT Analysis 19.3 Merck Serono Key Facts Business Overview Geographical Segmentation by Revenue Business Strategy Recent Developments SWOT Analysis 19.4 Novartis Key Facts Business Overview Business Segmentation by Revenue Business Segmentation by Revenue 2012 and Sales by Geography Business Strategy Key Developments SWOT Analysis 19.5 Teva Pharmaceuticals Key Facts Business Overview Business Segmentation Business Segmentation by Revenue Business Segmentation by Revenue 2012 and Sales by Geography Business Strategy Key Developments SWOT Analysis 20. Other Reports in this Series List of Exhibits Exhibit 1: Market Research Methodology Exhibit 2: Global Multiple Sclerosis Drugs Market (US$ billion) Exhibit 3: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type Exhibit 4: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type 2013 Exhibit 5: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type 2018 Exhibit 6: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type (US$ billion) Exhibit 7: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type (in percent) Exhibit 8: Global Biologics Market (US$ billion) Exhibit 9: Global Small Molecules Market (US$ billion) Exhibit 10: Global Multiple Sclerosis Drugs Market by Route of Administration

4 Exhibit 11: Global Multiple Sclerosis Drugs Market by Route of Administration 2013 Exhibit 12: Global Multiple Sclerosis Drugs Market by Route of Administration 2018 Exhibit 13: Global Multiple Sclerosis Drugs Market Segmentation by Route of Administration (US$ billion) Exhibit 14: Global Multiple Sclerosis Drugs Market Segmentation by Route of Administration (in percent) Exhibit 15: Global Oral Drugs Market (US$ billion) Exhibit 16: Global Parenteral Drugs Market (US$ billion) Exhibit 17: Global Multiple Sclerosis Drugs Market by Geography 2013 Exhibit 18: Multiple Sclerosis Market in the US (US$ billion) Exhibit 19: Global Multiple Sclerosis Drugs Market by Vendor Segmentation 2013 Exhibit 20: Global Sales Comparison of Betaseron/Betaferon (US$ million) Exhibit 21: Sales of Avonex (US$ million) Exhibit 22: Sales of Tysabri (US$ million) Exhibit 23: Sales of Fampyra (US$ million) Exhibit 24: Sales Comparison of Avonex, Tysabri and Fampyra (US$ million) Exhibit 25: Sales of Rebif (US$ million) Exhibit 26: Sales of Rebif in North America (US$ million) Exhibit 27: Sales of Rebif in Europe (US$ million) Exhibit 28: Sales of Rebif in Emerging Markets and RoW (US$ million) Exhibit 29: Geography-wise Sales of Rebif (US$ million) Exhibit 30: Sales of Gilenya (US$ million) Exhibit 31: Sales of Extavia (US$ million) Exhibit 32: Sales of Gilenya and Extavia (US$ million) Exhibit 33: Quarter-wise Sales of Copaxone (US$ million) Exhibit 34: Quarter-wise Sales of Copaxone in the US (US$ million) Exhibit 35: Quarter-wise Sales of Copaxone Outside the US (US$ million) Exhibit 36: Business Segmentation of Bayer AG 2013 Exhibit 37: Sales Comparison of Bayer AG by Business Segment 2012 and 2013 (US$ million) Exhibit 38: Sales Segmentation of Bayer AG by Geography 2013 Exhibit 39: Biogen Idec: Business Segmentation by Revenue 2013 Exhibit 40: Biogen Idec: Geographical Segmentation by Revenue 2013 Exhibit 41: Merck Serono: Geographical Segmentation by Revenue 2013 Exhibit 42: Novartis AG: Business Segmentation by Revenue 2013 Exhibit 43: Novartis AG: Business Segmentation by Revenue 2012 and 2013 (US$ million) Exhibit 44: Novartis AG: Sales by Geography 2013 Exhibit 45: Teva Pharmaceutical Industries Ltd.: Business Segmentation Exhibit 46: Teva Pharmaceutical Industries Ltd.: Business Segmentation by Revenue 2013 Exhibit 47: Teva Pharmaceutical Industries Ltd.: Business Segmentation by Revenue 2012 and 2013 (US$ million) Exhibit 48: Teva Pharmaceutical Industries Ltd.: Sales by Geography 2013 Ordering: Order Online - Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.

5 Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to (from USA) or (from Rest of World). If you have any questions please visit Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: Global Multiple Sclerosis Drugs Market Web Address: Office Code: Product Formats Please select the product formats and quantity you require: SC Single User: 1-5 Users: Site License: Enterprisewide: Quantity USD 3000 USD 3300 USD 4000 USD Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: Last Name: Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free accounts when ordering (e.g. Yahoo, Hotmail, AOL)

6 Page 1 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number Sort code Swift code IBAN number Bank Address ULSBIE2D IE78ULSB Ulster Bank, Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at Please fax this form to: (646) or (646) From USA or From Rest of World